These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 24168994)
1. Effect of intravitreal injection of bevacizumab on optic nerve head leakage and retinal ganglion cell survival in a mouse model of optic nerve crush. Rappoport D; Morzaev D; Weiss S; Vieyra M; Nicholson JD; Leiba H; Goldenberg-Cohen N Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8160-71. PubMed ID: 24168994 [TBL] [Abstract][Full Text] [Related]
2. Ocular Effects of Sildenafil in Naïve Mice and a Mouse Model of Optic Nerve Crush. Zahavi A; Weiss S; Vieyra M; Nicholson JD; Muhsinoglu O; Barinfeld O; Zadok D; Goldenberg-Cohen N Invest Ophthalmol Vis Sci; 2019 May; 60(6):1987-1995. PubMed ID: 31063183 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model. Kim KE; Jang I; Moon H; Kim YJ; Jeoung JW; Park KH; Kim H Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5641-9. PubMed ID: 26313300 [TBL] [Abstract][Full Text] [Related]
4. Methane rescues retinal ganglion cells and limits retinal mitochondrial dysfunction following optic nerve crush. Wang R; Sun Q; Xia F; Chen Z; Wu J; Zhang Y; Xu J; Liu L Exp Eye Res; 2017 Jun; 159():49-57. PubMed ID: 28336261 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats. Xie J; Jiang L; Zhang T; Jin Y; Yang D; Chen F Neurosci Lett; 2010 Jul; 479(1):26-30. PubMed ID: 20471452 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of inhibitors of Acid-Sensing ion channels (ASICs) in optic nerve crush model in rodents. Stankowska DL; Mueller BH; Oku H; Ikeda T; Dibas A Curr Eye Res; 2018 Jan; 43(1):84-95. PubMed ID: 29111855 [TBL] [Abstract][Full Text] [Related]
7. [Effect of VEGF-B on neuroprotection in mouse retinal ganglion cells]. Zhang SH; Yi Q Zhonghua Yan Ke Za Zhi; 2009 Jan; 45(1):38-42. PubMed ID: 19484929 [TBL] [Abstract][Full Text] [Related]
8. Celastrol supports survival of retinal ganglion cells injured by optic nerve crush. Kyung H; Kwong JM; Bekerman V; Gu L; Yadegari D; Caprioli J; Piri N Brain Res; 2015 Jun; 1609():21-30. PubMed ID: 25813825 [TBL] [Abstract][Full Text] [Related]
9. Monitoring retinal morphologic and functional changes in mice following optic nerve crush. Liu Y; McDowell CM; Zhang Z; Tebow HE; Wordinger RJ; Clark AF Invest Ophthalmol Vis Sci; 2014 May; 55(6):3766-74. PubMed ID: 24854856 [TBL] [Abstract][Full Text] [Related]
10. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Chen H; Weber AJ Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):966-74. PubMed ID: 11274073 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor-4 knockout mice are more resistant to optic nerve crush damage than wild-type mice. Morzaev D; Nicholson JD; Caspi T; Weiss S; Hochhauser E; Goldenberg-Cohen N Clin Exp Ophthalmol; 2015; 43(7):655-65. PubMed ID: 25752496 [TBL] [Abstract][Full Text] [Related]
13. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Levkovitch-Verbin H; Quigley HA; Kerrigan-Baumrind LA; D'Anna SA; Kerrigan D; Pease ME Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):975-82. PubMed ID: 11274074 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor. Jee D; Lee WK Curr Eye Res; 2012 May; 37(5):408-15. PubMed ID: 22040304 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load. Thaler S; Fiedorowicz M; Rejdak R; Choragiewicz TJ; Sulejczak D; Stopa P; Zarnowski T; Zrenner E; Grieb P; Schuettauf F Exp Eye Res; 2010 Feb; 90(2):254-60. PubMed ID: 19883642 [TBL] [Abstract][Full Text] [Related]
16. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611 [TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy. Tse BC; Dvoriantchikova G; Tao W; Gallo RA; Lee JY; Pappas S; Brambilla R; Ivanov D; Tse DT; Pelaez D Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2905-2912. PubMed ID: 30025145 [TBL] [Abstract][Full Text] [Related]
18. Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury. Schmitt HM; Schlamp CL; Nickells RW J Ocul Pharmacol Ther; 2018 Apr; 34(3):260-273. PubMed ID: 29211617 [TBL] [Abstract][Full Text] [Related]
19. α-Crystallin protects RGC survival and inhibits microglial activation after optic nerve crush. Wu N; Yu J; Chen S; Xu J; Ying X; Ye M; Li Y; Wang Y Life Sci; 2014 Jan; 94(1):17-23. PubMed ID: 24220677 [TBL] [Abstract][Full Text] [Related]
20. Apoptotic Retinal Ganglion Cell Death After Optic Nerve Transection or Crush in Mice: Delayed RGC Loss With BDNF or a Caspase 3 Inhibitor. Sánchez-Migallón MC; Valiente-Soriano FJ; Nadal-Nicolás FM; Vidal-Sanz M; Agudo-Barriuso M Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):81-93. PubMed ID: 26780312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]